GSK3B and neoplasm: A role for aberrant GSK3β in these tumor types is supported by the observation that pharmacological inhibition of its activity reduces the survival and proliferation of cancer cells and predisposes them to apoptosis in vitro and in tumor xenografts [9]–[12].